Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 5 (2008), Issue 12 (December)

1. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation.
   Cell Prolif, 41(6): 936-59. [Abstract] [Full-text]
2. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control.
   J Natl Cancer Inst, 100(23): 1672-94. [Abstract] [Full-text]
3. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.
   Nat Med, 14(12): 1351-6. [Abstract] [Full-text]
4. Dynamic proteomics of individual cancer cells in response to a drug.
   Science, 322(5907): 1511-6. [Abstract] [Full-text]
5. K-ras cancer gene mutations in lung tumors from female Swiss (CD-1) mice exposed transplacentally to 3'-azido-3'-deoxythymidine.
   Environ Mol Mutagen, 49(9): 720-6. [Abstract] [Full-text]
6. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
   Cancer Genet Cytogenet, 188(1): 26-31. [Abstract] [Full-text]
7. Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer.
   Int J Cancer, 124(1): 81-7. [Abstract] [Full-text]
8. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
   J Clin Oncol, 26(35): 5755-60. [Abstract] [Full-text]
9. Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer.
   Br J Cancer, 99(12): 2006-12. [Abstract] [Full-text]
10. Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.
    Br J Cancer, 99(12): 2013-9. [Abstract] [Full-text]
11. Overexpression of Sprouty 2 in mouse lung epithelium inhibits urethane-induced tumorigenesis.
    Am J Respir Cell Mol Biol, 40(1): 31-7. [Abstract] [Full-text]
12. Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth.
    Cancer Res, 68(24): 10377-86. [Abstract] [Full-text]
13. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy.
    Cancer Res, 68(24): 10247-56. [Abstract] [Full-text]
14. Phospholipase Cgamma1 is required for metastasis development and progression.
    Cancer Res, 68(24): 10187-96. [Abstract] [Full-text]
15. Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice.
    Int J Cancer, 124(2): 264-71. [Abstract] [Full-text]
16. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo.
    Mol Cell Biol, 29(1): 104-15. [Abstract] [Full-text]
17. Optical detection and grading of lung neoplasia by Raman microspectroscopy.
    Int J Cancer, 124(2): 376-80. [Abstract] [Full-text]
18. 15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.
    Int J Cancer, 123(12): 2741-9. [Abstract] [Full-text]
19. Systemic administration of hemoglobin vesicle elevates tumor tissue oxygen tension and modifies tumor response to irradiation.
    J Surg Res, 151(1): 48-54. [Abstract] [Full-text]
20. Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer.
    Cancer Lett, 273(2): 331-5. [Abstract] [Full-text]
21. Confirmation of gene expression-based prediction of survival in non-small cell lung cancer.
    Clin Cancer Res, 14(24): 8213-20. [Abstract] [Full-text]
22. A mouse model for EML4-ALK-positive lung cancer.
    Proc Natl Acad Sci U S A, 105(50): 19893-7. [Abstract] [Full-text]
23. The chromosome 3p21.3-encoded gene, LIMD1, is a critical tumor suppressor involved in human lung cancer development.
    Proc Natl Acad Sci U S A, 105(50): 19932-7. [Abstract] [Full-text]
24. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up.
    Radiology, 250(1): 264-72. [Abstract] [Full-text]
25. Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells.
    J Med Chem, 51(24): 8109-14. [Abstract] [Full-text]
26. Elevated serum leptin levels: a risk factor for non-small-cell lung cancer?
    Oncology, 76(1): 19-25. [Abstract] [Full-text]
27. Choroidal metastasis from an occult primary diagnosed by fine-needle aspiration: a case report.
    Diagn Cytopathol, 37(1): 38-41. [Abstract] [Full-text]
28. Lung cancer A549 cells migrate directionally in DC electric fields with polarized and activated EGFRs.
    Bioelectromagnetics, 30(1): 29-35. [Abstract] [Full-text]
29. Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.
    J Clin Oncol, 26(36): 5972-9. [Abstract] [Full-text]
30. Primary pulmonary adenocarcinoma with intestinal differentiation mimicking metastatic colorectal carcinoma: case report and review of literature.
    Am J Clin Pathol, 131(1): 129-33. [Abstract] [Full-text]
31. Evidence-based criteria to help distinguish metastatic breast cancer from primary lung adenocarcinoma on thoracic frozen section.
    Am J Clin Pathol, 131(1): 122-8. [Abstract] [Full-text]
32. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
    Bone, 44(1): 173-5. [Abstract] [Full-text]
33. Does chemotherapy increase morbidity and mortality after pneumonectomy?
    J Surg Oncol, 99(1): 38-41. [Abstract] [Full-text]
34. Coiling of major aortopulmonary collateral arteries with agenesis of the left pulmonary artery prior to pneumonectomy.
    Ann Thorac Surg, 87(1): 312-4. [Abstract] [Full-text]
35. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach?
    Ann Thorac Surg, 87(1): 238-43. [Abstract] [Full-text]
36. Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation.
    Ann Thorac Surg, 87(1): e6-7. [Abstract] [Full-text]
37. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 73(1): 94-102. [Abstract] [Full-text]
38. High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling.
    Am J Respir Crit Care Med, 179(1): 59-68. [Abstract] [Full-text]
39. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
    Mol Pharmacol, 75(1): 196-207. [Abstract] [Full-text]
40. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.
    Am J Respir Crit Care Med, 179(1): 69-74. [Abstract] [Full-text]
41. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy.
    Int J Radiat Oncol Biol Phys, 73(1): 112-8. [Abstract] [Full-text]
42. Clinical images. Gastric perforation caused by metastatic lung carcinoma.
    Am J Surg, 197(1): e5-6. [Abstract] [Full-text]
43. FDG-PET-based radiotherapy planning in lung cancer: optimum breathing protocol and patient positioning--an intraindividual comparison.
    Int J Radiat Oncol Biol Phys, 73(1): 103-11. [Abstract] [Full-text]
44. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 73(1): 119-27. [Abstract] [Full-text]
45. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes.
    Int J Radiat Oncol Biol Phys, 73(1): 128-35. [Abstract] [Full-text]
46. Usefulness of concurrent reading using thin-section and thick-section CT images in subcentimetre solitary pulmonary nodules.
    Clin Radiol, 64(2): 127-32. [Abstract] [Full-text]
47. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung.
    Jpn J Clin Oncol, 39(1): 33-6. [Abstract] [Full-text]
48. Pyrogallol inhibits the growth of lung cancer Calu-6 cells via caspase-dependent apoptosis.
    Chem Biol Interact, 177(2): 107-14. [Abstract] [Full-text]
49. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
    Jpn J Clin Oncol, 39(1): 27-32. [Abstract] [Full-text]
50. Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer.
    Thorax, 64(1): 75-80. [Abstract] [Full-text]
51. Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study.
    Cancer Chemother Pharmacol, 63(3): 403-9. [Abstract] [Full-text]
52. The changing epidemiology of lung cancer.
    Methods Mol Biol, 472: 397-411. [Abstract] [Full-text]
53. Lung cancer and exposure to metals: the epidemiological evidence.
    Methods Mol Biol, 472: 139-67. [Abstract] [Full-text]
54. Environmental and occupational risk factors for lung cancer.
    Methods Mol Biol, 472: 3-23. [Abstract] [Full-text]
55. Tuberculosis and subsequent risk of lung cancer in Xuanwei, China.
    Int J Cancer, 124(5): 1183-7. [Abstract] [Full-text]
56. CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.
    Cancer Lett, 274(1): 160-4. [Abstract] [Full-text]
57. Mutations of lysophosphatidic acid receptor-1 gene during progression of lung tumors in rats.
    Biochem Biophys Res Commun, 378(3): 424-7. [Abstract] [Full-text]
58. Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature.
    Urology, 73(1): 210.e3-5. [Abstract] [Full-text]
59. Linear and volume measurements of pulmonary nodules at different CT dose levels - intrascan and interscan analysis.
    Rofo, 181(1): 24-31. [Abstract] [Full-text]
60. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.
    J Clin Oncol, 27(1): 78-84. [Abstract] [Full-text]
61. Does a patient-held quality-of-life diary benefit patients with inoperable lung cancer?
    J Clin Oncol, 27(1): 70-7. [Abstract] [Full-text]
62. Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: a pilot randomized and placebo-controlled clinical trial.
    Complement Ther Med, 17(1): 51-5. [Abstract] [Full-text]

© 2004-2010 Lung Cancer Research Today. All Rights Reserved.